Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cells|December 28, 2017
Induced Pluripotent Stem Cell-Derived Red Blood Cells and Platelet Concentrates: From Bench to BedsideDaniele Focosi, Giovanni Amabile
Trends in Molecular Medicine|January 24, 2009
Induced pluripotent stem cells: current progress and potential for regenerative medicineGiovanni Amabile, Alexander Meissner
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 6, 2025
Clinical applications of oligonucleotides for cancer therapyVittorio DeFranciscis, Giovanni Amabile, Marcin Kortylewski
Cells|August 26, 2022
SALL4: An Intriguing Therapeutic Target in Cancer TreatmentShiva Moein, Daniel G Tenen, Giovanni Amabile, et al.
Molecular & Cellular Oncology|June 18, 2016
The second hit of DNA methylationAnnalisa Di Ruscio, Robert S Welner, Daniel G Tenen, et al.
Gene|February 20, 2016
SALL4, the missing link between stem cells, development and cancerHiro Tatetsu, Nikki R Kong, Gao Chong, et al.
Molecular Cancer Research : MCR|July 20, 2006
An autocrine loop involving ret and glial cell-derived neurotrophic factor mediates retinoic acid-induced neuroblastoma cell differentiationLaura Cerchia, Amelia D'Alessio, Giovanni Amabile, et al.
Blood|October 14, 2006
The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitorBarbara Ghinassi, Massimo Sanchez, Fabrizio Martelli, et al.
Blood Cells, Molecules & Diseases|August 2, 2005
Isolation of TPO-dependent subclones from the multipotent 32D cell lineGiovanni Amabile, Antonella Di Noia, Elena Alfani, et al.
Molecular Cancer Therapeutics|May 17, 2008
Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cellsAnna Morena D'Alise, Giovanni Amabile, Mariangela Iovino, et al.
Pageof 3